Cotations Graphiques Analyse Technique Graphique Statique Graphique Actualités Graphique Sectoriel Graphique Comparatif Graphique Force Relative Actualités Toute l'actualité Reco analystes Faits ...

This 2 nd interim analysis is to be performed by the independent DMC (Data Monitoring Committee) based on safety and efficacy data The Company is to report the recommendation from the DMC based on its ...

Ce rating composite est le résultat d'une moyenne des classements selon les ratings Fondamentaux (Composite), Valorisation (Composite), Révisions Fondamentaux (Composite), Consensus (Composite) et ...

Sarconeos (BIO101) at the highest dose (350 mg bid) showed a clinically meaningful improvement in the 400-Meter Walk Test (400MWT), the primary endpoint of the study, including in sub-populations at ...

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company ...

The independent DMC (Data Monitoring Committee) of the COVA study recommends to continue patients recruitment into Part 2 of the phase 2-3 study following randomization of the first 155 patients ...

(Boursier.com) — La société de biotechnologie au stade clinique Biophytis reporte la publication de ses comptes annuels, clos ...